Immix Biopharma (IMMX) Stock Forecast & Price Target
IMMX Analyst Ratings
Strong Buy
6Buy0Hold0Sell
Based on 6 analysts giving stock ratings to Immix Biopharma in the past 3 months
IMMX Stock 12 Month Forecast
Average Price Target
$25.33▲(248.94% Upside)Based on 6 Wall Street analysts offering 12 month price targets for Immix Biopharma in the last 3 months. The average price target is $25.33 with a high forecast of $30.00 and a low forecast of $20.00. The average price target represents a 248.94% change from the last price of $7.26.
Past 12 Months12 Month ForecastDec2025Sep2026
High$30.00
Average$25.33
Low$20.00
Highest Price TargetHighest$30.00Average Price Target$25.33Lowest Price TargetLowest$20.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Graig Suvannavejh | Mizuho Securities | $26→$23 | buy | 216.80%Upside | Reiterated | 10/29/26 | ||
| Judah Frommer | Morgan Stanley | $19→$20 | buy | 175.48%Upside | Assigned | 10/20/26 | ||
| Patrick Dolezal | LifeSci Capital | $24 | buy | 230.58%Upside | Reiterated | 10/03/26 | ||
| Tazeen Ahmad | Bank of America Securities | $27→$30 | buy | 313.22%Upside | Reiterated | 09/29/26 | ||
| Gil Blum | Needham | $21→$30 | buy | 313.22%Upside | Reiterated | 09/29/26 | ||
| Robert Burns | H.C. Wainwright | $20→$25 | buy | 244.35%Upside | Reiterated | 08/10/26 | ||
| Reni Benjamin | Citizens JMP | $23 | buy | 216.80%Upside | Initiated | 03/09/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Graig Suvannavejh | 10/29/26 | $26→$23 | buy | 216.80%Upside | Reiterated | Mizuho Securities | ||
| Judah Frommer | 10/20/26 | $19→$20 | buy | 175.48%Upside | Assigned | Morgan Stanley | ||
| Patrick Dolezal | 10/03/26 | $24 | buy | 230.58%Upside | Reiterated | LifeSci Capital | ||
| Tazeen Ahmad | 09/29/26 | $27→$30 | buy | 313.22%Upside | Reiterated | Bank of America Securities | ||
| Gil Blum | 09/29/26 | $21→$30 | buy | 313.22%Upside | Reiterated | Needham | ||
| Robert Burns | 08/10/26 | $20→$25 | buy | 244.35%Upside | Reiterated | H.C. Wainwright | ||
| Reni Benjamin | 03/09/26 | $23 | buy | 216.80%Upside | Initiated | Citizens JMP |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Immix Biopharma
3 Months
Success Rate8/13 ratings generated profit
62%
Average Return
+34.88%
Copying Robert Burns's trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +34.88% per trade.
1 Year
Success Rate10/13 ratings generated profit
77%
Average Return
+126.71%
Copying Robert Burns's trades and holding each position for 1 Year would result in 76.92% of your transactions generating a profit, with an average return of +126.71% per trade.
2 Years
Success Rate10/13 ratings generated profit
77%
Average Return
+227.92%
Copying Robert Burns's trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +227.92% per trade.
IMMX Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 4 | 6 | 7 | 11 | 12 |
| Buy | 1 | 0 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 5 | 6 | 9 | 13 | 14 |
In the current month, IMMX has received 14 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IMMX average Analyst price target in the past 3 months is 25.33.
IMMX Financial Forecast
IMMX Earnings Forecast
Next quarter’s earnings estimate for IMMX is -$0.72 with a range of ― to ―. The previous quarter’s EPS was ―. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
IMMX Stock Forecast FAQ
What is IMMX’s average 12-month price target, according to analysts?
Based on analyst ratings, Immix Biopharma’s 12-month average price target is $25.33.
What is IMMX’s upside potential, based on the analysts’ average price target?
Immix Biopharma has 248.94% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IMMX a Buy, Sell or Hold?
Immix Biopharma has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
What is Immix Biopharma’s price target?
The average price target for Immix Biopharma is $25.33. This is based on 6 12-month price targets, issued in the past 3 months. The highest analyst price target is $30.00, the lowest forecast is $20.00. The average price target represents a 248.94% increase from the current price of $7.26.
What do analysts say about Immix Biopharma?
Immix Biopharma’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Street analysts.
How can I buy shares of IMMX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
